[HTML][HTML] Recent developments of topoisomerase inhibitors: Clinical trials, emerging indications, novel molecules and global sales

AD Bondarev, J Jonsson, VN Chubarev… - Pharmacological …, 2024 - Elsevier
The nucleic acid topoisomerases (TOP) are an evolutionary conserved mechanism to solve
topological problems within DNA and RNA that have been historically well-established as a …

Insights into durability against resistance from the antibiotic nitrofurantoin

R Kettlewell, C Jones, TW Felton, M Lagator… - npj Antimicrobials and …, 2024 - nature.com
Nitrofurantoin has shown exceptional durability against resistance over 70 years of use. This
longevity stems from factors such as rapid achievement of therapeutic concentrations …

[PDF][PDF] Fluoroquinolone resistance determinants in carbapenem-resistant Escherichia coli isolated from urine clinical samples in Thailand

P Boueroy, P Chopjitt, R Hatrongjit, M Morita… - PeerJ, 2023 - peerj.com
Background. Escherichia coli is the most common cause of urinary tract infections and has
fluoroquinolone (FQ)-resistant strains, which are a worldwide concern. Objectives. To …

Uropathogens' antibiotic resistance evolution in a female population: A sequential multi-year comparative analysis

C Mareș, RC Petca, RI Popescu, A Petca, BF Geavlete… - Antibiotics, 2023 - mdpi.com
Urinary Tract Infections (UTIs) represent a common finding among females and an important
basis for antibiotic treatment. Considering the significant increase in antibiotic resistance …

Epidemiological insights into seasonal, sex‑specific and age‑related distribution of bacterial pathogens in urinary tract infections

ZS Zhan, J Shi, ZS Zheng, XX Zhu… - Experimental and …, 2024 - spandidos-publications.com
Urinary tract infections (UTIs) are prevalent and recurrent bacterial infections that affect
individuals worldwide, posing a significant burden on healthcare systems. The present study …

Comparative study of virulence potential, phylogenetic origin, CRISPR-Cas regions and drug resistance of Escherichia coli isolates from urine and other clinical …

A Dziuba, S Dzierżak, A Sodo… - Frontiers in …, 2023 - frontiersin.org
Introduction Urinary tract infections (UTI), among which the main etiological factor is
uropathogenic Escherichia coli (UPEC, E. coli), remain an important issue for clinicians. The …

The global burden of antimicrobial resistance–urinary tract infections

S Von Vietinghoff, O Shevchuk… - Nephrology Dialysis …, 2024 - academic.oup.com
Antimicrobial resistance (AMR) has emerged as a significant global healthcare problem.
Antibiotic use has accelerated the physiologic process of AMR, particularly in Gram-negative …

Antimicrobial activity of ceftibuten-avibactam against a global collection of Enterobacterales from patients with urinary tract infections (2021)

HS Sader, CG Carvalhaes, MD Huband… - European Journal of …, 2023 - Springer
We evaluated the in vitro activity of ceftibuten-avibactam against Enterobacterales causing
urinary tract infection (UTI). A total of 3216 isolates (1/patient) were consecutively collected …

Streptococcus pneumoniae favors tolerance via metabolic adaptation over resistance to circumvent fluoroquinolones

TH Dao, H Echlin, A McKnight, ES Marr, J Junker, Q Jia… - Mbio, 2024 - Am Soc Microbiol
Streptococcus pneumoniae is a major human pathogen of global health concern and the
rapid emergence of antibiotic resistance poses a serious public health problem worldwide …

Role of N-acetylkynurenine in mediating the effect of gut microbiota on urinary tract infection: a Mendelian randomization study

Y He, C Han, C Li, X Yin, J Wang, L Gu, R Yan… - Frontiers in …, 2024 - frontiersin.org
Introduction This study explored the causal connections between gut microbiota (GM),
urinary tract infection (UTI), and potential metabolite mediators using Mendelian …